Belite Bio, Inc American Depositary Shares
Symbol: BLTE (NASDAQ)
0.00
▼ (-100.00%) -66.900
Company Description:
Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.
Key Stats
- Today's Open: $0
- Today's High: $0
- Today's Low: $0
- Today's Volume: 0
- Yesterday Close: $66.9
- Yesterday High: $68.17
- Yesterday Low: $64.8
- Yesterday Volume: 65.06K
- Last Min Volume: 0
- Last Min High: $0
- Last Min Low: $0
- Last Min VWAP: $0
Company Profile
- Name: Belite Bio, Inc American Depositary Shares
- Website: https://www.belitebio.com
- Listed Date: 2022-04-29
- Location: ,
- Market Status: Active
- CIK Number: 0001889109
- SIC Code:
- SIC description:
- Market Cap: $2.19B
- Round Lot: 100
- Outstanding Shares: 32.83M
- Asset Type: ADRC
RECENT FILINGS FOR BLTE
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-08 | 6-K | View |
| 2025-08-21 | 144 | View |
| 2025-08-11 | 6-K | View |
| 2025-08-08 | 424B5 | View |
| 2025-08-07 | 6-K | View |
| 2025-07-02 | 6-K | View |
| 2025-05-21 | 144 | View |
| 2025-05-21 | 6-K | View |
| 2025-05-14 | 6-K | View |
| 2025-04-15 | 6-K | View |
| 2025-03-28 | 6-K | View |
| 2025-03-21 | S-8 | View |
| 2025-03-19 | 144 | View |
| 2025-03-18 | 6-K | View |
| 2025-03-17 | 6-K | View |
| 2025-03-17 | 6-K | View |
| 2025-03-17 | 20-F | View |
| 2025-02-27 | 6-K | View |
| 2025-02-07 | 424B5 | View |
| 2025-02-06 | 6-K | View |